Skip to content
Politically.com Search all
Menu

2026 · 2nd Quarter (Apr 1 - June 30)

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

Filed by TODD STRATEGY GROUP.

Open official filing
Source: Lobbying Disclosure APIRecently refreshed. 2026-08-03 06:26:15 UTC.

Source-reported fields

Filing overview

Type
2nd Quarter - Report
Posted
Jul 21, 2026
Income
$80,000.00
Expenses
Not reported
Filing UUID
fcf9aa93-2921-4d25-848e-419e71b396ce
Termination date
Not reported

Literal source text

Lobbying issues and bill citations

MMM · Medicare/Medicaid

Part D changes. Prescription drug payment reform. 340B issues. Onshoring. S.864: HELP Copays Act. General Medicare and Medicaid Issues.

Literal federal measure citations: S.864

PHA · Pharmacy

Drug Pricing and Access. Pharmaceutical Supply Chain. Pharmacy Benefit Managers.

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.